2024

1. 3-year invasive disease-free survival with chemotherapy de-escalation using an 18F-FDG-PET-based, pathological complete response-adapted strategy in HER2-positive early breast cancer (PHERGain): a randomised, open-label, phase 2 trial

   The Lancet, Vol. 403, Núm. 10437, pp. 1649-1659

2. A randomised trial of short- vs long-term androgen deprivation with salvage radiotherapy for biochemical failure following radical prostatectomy: URONCOR 06-24

   BJU International, Vol. 134, Núm. 4, pp. 568-577

3. A two-years real-word study with fingolimod: early predictors of efficacy and an association between EBNA-1 IgG titers and multiple sclerosis progression

   Frontiers in Immunology, Vol. 15

4. APOE genotype, hippocampal volume, and cognitive reserve predict improvement by cognitive training in older adults without dementia: a randomized controlled trial

   Cognitive Processing

5. Acceptability of Long-Acting Injectable Antiretroviral Treatment for HIV Management: Perspectives of Patients and Physicians in Spain

   AIDS Patient Care and STDs, Vol. 38, Núm. 7, pp. 305-314

6. Apparent Diffusion Coefficient as an Early Prognostic Factor of Response to Treatment with Androgen Deprivation Therapy and Radiotherapy in Patients with Prostate Cancer (Póster)

   International Journal of Radiation Oncology*Biology*Physics, Vol. 120, Núm. 2, pp. e527

7. Association of MicroRNA Expression and Serum Neurofilament Light Chain Levels with Clinical and Radiological Findings in Multiple Sclerosis

   International Journal of Molecular Sciences, Vol. 25, Núm. 18

8. Baroreflex activation therapy in patients with heart failure and reduced ejection fraction

   Revista Espanola de Cardiologia, Vol. 77, Núm. 4, pp. 342-344

9. Basic action protocol for the outpatient management of chronic heart failure of the Spanish Society of Internal Medicine

   Revista Clinica Espanola

10. CDH1 methylation analysis in invasive lobular breast carcinomas with and without gene mutation

    Virchows Archiv, Vol. 485, Núm. 2, pp. 291-297

11. Cardiovascular surgery and cardiology, current status of two sister specialties in Spain: the CARDIOXCARDIO study

    Revista Espanola de Cardiologia, Vol. 77, Núm. 9, pp. 759-766

12. Cardiovascular surgery and cardiology, current status of two sister specialties in Spain: the CARDIOXCARDIO study

    Cirugia Cardiovascular, Vol. 31, Núm. 5, pp. 185-192

13. Chromosomal breaks: another differential gap between early-onset and late-onset colorectal cancers

    British Journal of Surgery, Vol. 111, Núm. 3

14. Clinical impact of remote heart failure management using the multiparameter ICD HeartLogic alert

    Revista Espanola de Cardiologia

15. Clinical practice guideline on the management of vestibular schwannoma

    Acta Otorrinolaringologica Espanola, Vol. 75, Núm. 2, pp. 108-128

16. Clinical suspicion, diagnosis and management of cardiac amyloidosis: update and executive summary

    Revista Clinica Espanola, Vol. 224, Núm. 5, pp. 288-299

17. Clinicopathological and molecular predictors of [18F]FDG-PET disease detection in HER2-positive early breast cancer: RESPONSE, a substudy of the randomized PHERGain trial

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 51, Núm. 9, pp. 2733-2743

18. Colchicine in acute heart failure: Rationale and design of a randomized double-blind placebo-controlled trial (COLICA)

    European Journal of Heart Failure

19. Combinational Diuretics in Heart Failure

    Current Heart Failure Reports, Vol. 21, Núm. 4, pp. 1-11

20. Combining Loop and Thiazide Diuretics Across the Left Ventricular Ejection Fraction Spectrum: The CLOROTIC Trial

    JACC: Heart Failure, Vol. 12, Núm. 10, pp. 1719-1730